# IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/il12-immune-therapy-clinical-trial-review-novel-strategies-for-avoiding-crs/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Zhiliang Jia,Dristhi Ragoonanan,Kris M. Mahadeo,Jonathan Gill,Richard Görlick,Elizabeth Shpal,Shulin Li |
| Citations | 92 |
| DOI | 10.3389/fimmu.2022.952231 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fimmu.2022.952231/pdf |
| OpenAlex ID | https://openalex.org/W4297907002 |
| PMID | 36203573 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Jonathan Gill](https://scholariq.org/researchers/jonathan-gill/)

## Paper journal

- [Frontiers in Immunology](https://scholariq.org/journals/frontiers-in-immunology/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.